Aquestive Therapeutics Inc. (NASDAQ: AQST) reported Q1 EPS of ($0.24), $0.08 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $8.7 million versus the consensus estimate of $12.23 million.

For earnings history and earnings-related data on Aquestive Therapeutics Inc. (AQST) click here.